PTPRC and breast carcinoma: Interestingly, in 4T1 breast cancer mouse model, metformin treatment significantly increases CD11c+ F4/80− CD11b+ B220− cDCs and in CD11c+ F4/80− CD11b− B220+ pDCs [63].